Multi-channel blockers for treatment of atrial fibrillation: an effective strategy?

Cardiovascular Research: March 1, 2013

Atrial fibrillation (AF) is the most common arrhythmia and one of the most vexing cardiovascular conditions for patients and the physicians who care for them. AF is a primary cause of cardioembolic stroke and may account for more than 20% of all stroke cases in older individuals.1 While AF can easily be diagnosed by electrocardiography, many cases of AF are undetected due to the lack of symptoms. Lifetime risk for developing AF after an age of 40 years is ∼25% for both men and women. The prevalence of AF has been increasing, due to both ageing of the population and an increased prevalence of risk factors such as obesity and sedentary lifestyle. The personal and societal economic consequences of AF are staggering. Read more

National Minority Quality Forum
Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2011 National Minority Quality Forum, Inc. All Rights Reserved.